Biden Announces Plan to Buy 100 Million More Doses of J&J Vaccine
THURSDAY, March 11, 2021 -- An additional 100 million doses of the Johnson & Johnson single-shot COVID-19 vaccine will be ordered by the U.S. government by the end of the year, President Joe Biden announced Wednesday.
The move means there should be enough doses on hand to vaccinate children and, if necessary, give booster doses or reformulate the vaccine to combat emerging, more contagious variants of the virus, The New York Times reported. The announcement came during a White House meeting Biden held with executives from Johnson & Johnson and the pharmaceutical giant Merck. The rival companies are partnering to ramp up production of the Johnson & Johnson vaccine in a deal brokered by the White House.
Biden has said that every American adult -- roughly 260 million people -- will have access to a vaccine by the end of May. But the senior officials said the administration was trying to prepare for unexpected challenges, The Times reported.
The officials said that they expected the doses to be delivered sometime in the second half of this year, the newspaper said. The Biden Administration has said the J&J/Merck collaboration will boost production and improve the J&J packaging capacity, known in the vaccine industry as "fill-finish" -- two big bottlenecks that have put the company behind schedule.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Further Support and Information on COVID-19
Read this next
FRIDAY, April 16, 2021 -- For persons with a history of previous infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the neutralizing antibody titer is...
FRIDAY, April 16, 2021 -- Vaccinated Americans will probably need booster shots to guard against emerging coronavirus variants in the future, a White House adviser and Pfizer said...
FRIDAY, April 16, 2021 -- COVID-19 ups the risk for death with hemorrhagic stroke by more than twofold, according to a study published online April 14 in PLOS ONE. Vijay M....
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.